Drug & Supplement Interactions

Cannabis + Docusate

Brand name of Docusate

  • Colace

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated October 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line No Known Interaction

We found no known interaction between Cannabis and Docusate in our sources.

This also applies to Colace, a brand name of docusate.

See the Full Interaction Report

Ask a Question About This Combination

Ask in your own words about taking Cannabis with Docusate. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Cannabis and Docusate Interaction Check

No Known Interaction Found

We did not find a documented interaction between Docusate and Cannabis in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Still wondering about combining Cannabis and Docusate? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
Know someone taking this combination? Share
What to Watch For

What Cannabis Itself Has Been Linked To

  • This is not an interaction: nothing below involves Docusate.
  • It is the side-effect record for Cannabis on its own, from the licensed Natural Medicines monograph.
  • If something new turns up after you add Cannabis, this list is the first place to look.
  • 6 entries are worth acting on rather than waiting out, marked below.
  • An electrolyte imbalance / Kidney stones Worth Acting On Additional detail

    Smoking and ingesting cannabis can cause xerostomia, nausea, and vomiting (13,18,2619,61896,96384,96813,113016,118172). Vaping cannabis has been reported to cause sore throat and bad taste in up to 35% of patients. Cannabis has also been reported to cause oral candidiasis. There have been 2 case reports of tongue candidiasis attributed to dry mouth after heavy cannabis use.

    Source: , the clinical database we license.

    6 references cited
    1. 13. Robbers JE, Speedie MK, Tyler VE. Pharmacognosy and Pharmacobiotechnology. Baltimore, MD: Williams & Wilkins, 1996.
    2. 18. Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc., 1998.
    3. 2619. Hebel SK, ed. Drug Facts and Comparisons. 52nd ed. St. Louis: Facts and Comparisons, 1998.
    4. 61896. Lynch, M. E. and Campbell, F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br.J.Clin.Pharmacol. 2011;72(5):735-744. PubMed
    5. 96384. Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: A systematic review and meta-analysis. JAMA. 2015;313(24):2456-73. PubMed
    6. 96813. Lotan I, Treves TA, Roditi Y, Djaldetti R. Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study. Clin Neuropharmacol. 2014;37(2):41-4. PubMed

    Acute kidney injury has been reported after oral cannabis use. In one case, it was likely caused by pre-existing mild dehydration related to a lack of fluid intake, followed by cannabis-induced diarrhea.

    Source: , the clinical database we license.

    6 references cited
    1. 111071. Moussa MK, Hall MAK, Akwe J. Cannabis-induced acute encephalopathy in a 94-year-old woman due to family administration of cannabidiol (CBD) products: A case report. Cureus 2023;15(4):e37927.
    2. 115363. Yang G, Li F, Wang Q, Liu Y, Guo J, Yue C. Association between history of cannabis use and outcomes after total hip or knee arthroplasty: a systematic review and meta-analysis. Front Public Health 2024;12:1377688. PubMed
    3. 110240. Chabot C, Gouat F. Rare finding of acute eosinophilic pneumonia associated with heavy cannabis use: A case-report. Radiol Case Rep 2022;17(9):3040-3042. PubMed
    4. 99585. Nourbakhsh M, Miller A, Gofton J, Jones G, Adeagbo B. Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases. J Forensic Sci. 2019;64(1):270-274. PubMed
    5. 101423. Chocron Y, Zuber JP, Vaucher J. Cannabinoid hyperemesis syndrome. BMJ. 2019 Jul 19;366:l4336. PubMed
    6. 101424. Kheifets M, Karniel E, Landa D, Vons SA, Meridor K, Charach G. Resolution of Cannabinoid Hyperemesis Syndrome with Benzodiazepines: A Case Series. Isr Med Assoc J. 2019 Jun;21(6):404-407.
  • Mania or an unusually elevated mood / Dependence or withdrawal symptoms / Thoughts of self-harm Worth Acting On Additional detail

    Cannabis-based medicines, especially THC-dominant products, are associated with an increased risk of psychiatric adverse effects. A meta-analysis of available research shows that THC-dominant cannabis-based medicines increase psychiatric effects such as anxiety, confusion, dysphoria, and perceptual disturbances compared with control.

    When used short-term, smoking cannabis or using oromucosal spray containing cannabis…

    Source: , the clinical database we license.

    6 references cited
    1. 118162. Ates G, Welsch P, Klose P, et al. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2026;1(1):CD012182. PubMed
    2. 61896. Lynch, M. E. and Campbell, F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br.J.Clin.Pharmacol. 2011;72(5):735-744. PubMed
    3. 96814. Duran M, Pérez E, Abanades S, et al. Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. Br J Clin Pharmacol. 2010;70(5):656-63. PubMed
    4. 110242. Englund A, Oliver D, Chesney E, et al. Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios. Neuropsychopharmacology 2022. PubMed
    5. 110254. Hutten NRPW, Arkell TR, Vinckenbosch F, et al. Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis. Psychopharmacology (Berl) 2022;239(11):3731-374 PubMed
    6. 99583. Lawn W, Freeman TP, Pope RA, et al. Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses. Psychopharmacology (Berl). 2016;233(19-20):3537-52. PubMed
  • Loss of vision Worth Acting On Additional detail

    The use of inhaled cannabis can cause a characteristic reddening of the eyes. Smoking cannabis can also cause dry eyes. Acute poisoning from cannabis can cause lacrimation (18). Orally, in children ages 12 years and younger, accidental ingestion of cannabis-containing edibles has been associated with nystagmus.

    Source: , the clinical database we license.

    6 references cited
    1. 2619. Hebel SK, ed. Drug Facts and Comparisons. 52nd ed. St. Louis: Facts and Comparisons, 1998.
    2. 96389. Ocampo TL, Rans TS. Cannabis sativa: the unconventional "weed" allergen. Ann Allergy Asthma Immunol. 2015;114(3):187-92. PubMed
    3. 17371. Ware MA, Wang T, Shapiro S, et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ 2010;182:e694-e701. PubMed
    4. 18. Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc., 1998.
    5. 103793. Ammerman SD, Ryan SA, Adelman WP, et al. The impact of marijuana policies on youth: clinical, research, and legal update. Pediatrics. 2015;135(3):584-7. DOI
    6. 103794. Emoto J, Weeks K, Kallail KJ. Accidental Acute Cannabis Intoxication Presenting as Seizure in Pediatrics Patients. Kans J Med. 2020;13: 129-130. DOI
  • Serotonin syndrome Worth Acting On Additional detail

    Smoking, vaping, or ingesting cannabis can cause headache, dizziness, numbness, disorientation, somnolence, and fatigue. Recurrent, strong headaches associated with cannabis use might be related to reversible cerebral vasoconstriction syndrome (RCVS). In one cohort, 32% of individuals with RCVS were cannabis users.

    Source: , the clinical database we license.

    6 references cited
    1. 17371. Ware MA, Wang T, Shapiro S, et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ 2010;182:e694-e701. PubMed
    2. 61896. Lynch, M. E. and Campbell, F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br.J.Clin.Pharmacol. 2011;72(5):735-744. PubMed
    3. 96384. Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: A systematic review and meta-analysis. JAMA. 2015;313(24):2456-73. PubMed
    4. 96813. Lotan I, Treves TA, Roditi Y, Djaldetti R. Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study. Clin Neuropharmacol. 2014;37(2):41-4. PubMed
    5. 101420. van de Donk T, Niesters M, Kowal MA, Olofsen E, Dahan A, van Velzen M. An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia. Pain. 2019 Apr;160(4):860-869. PubMed
    6. 113016. Chhabra M, Ben-Eltriki M, Paul A, Lê ML, Herbert A, Oberoi S, Bradford N, Bowers A, Rassekh SR, Kelly LE. Cannabinoids for symptom management in children with cancer: A systematic review and meta-analysis. Cancer. 2023 Nov 15;129(22):3656-3670. doi: 10.10 PubMed
  • A stroke or mini-stroke Worth Acting On Additional detail

    Cannabis use is associated with an increased risk of adverse cardiovascular events. A meta-analysis of observational studies in approximately 1.9 million adults suggests that cannabis use is associated with a 48% increased relative risk of a composite of adverse cardiovascular events compared with non-use.

    Cannabis has also been associated with acute coronary syndrome (ACS).

    Source: , the clinical database we license.

    6 references cited
    1. 118176. Sebastian SA, Shah Y, Arsene C, Krishnamoorthy G. Cannabis use and atherosclerotic cardiovascular disease outcomes: A meta-analysis of multinational cohort data. Dis Mon 2025;71(3):101849. PubMed
    2. 91920. Jouanjus E, Lapeyre-Mestre M, Micallef J; French Association of the Regional Abuse and Dependence Monitoring Centres (CEIP-A) Working Group on Cannabis Complications. Cannabis use: signal of increasing risk of serious cardiovascular disorders. J Am Heart PubMed
    3. 96378. Goyal H, Awad HH, Ghali JK. Role of cannabis in cardiovascular disorders. J Thorac Dis. 2017;9(7):2079-2092. PubMed
    4. 104491. Lawin D, Lawrenz T, Tego A, Stellbrink C. Cannabis-induced recurrent myocardial infarction in a 21-year-old man: a case report. Eur Heart J Case Rep. 2020;4(3):1-5. PubMed
    5. 108688. Kasuda S, Kondo T, Terazawa I, Morimoto M, Yuui K, Kudo R. Cardiac sudden death in a young cannabis user. Leg Med (Tokyo) 2021;53:101955. PubMed
    6. 116443. Storck W, Elbaz M, Vindis C, et al. Cardiovascular risk associated with the use of cannabis and cannabinoids: a systematic review and meta-analysis. Heart. 2025:heartjnl-2024-325429. PubMed
  • Severe muscle breakdown / Bone thinning Worth Acting On Additional detail

    Meta-analyses of up to 3 observational studies in adults with recent total hip or knee arthroplasty suggests that a history of cannabis use is associated with a greater risk of postoperative surgical revision, dislocation, mechanical loosening of prosthesis, periprosthetic fracture, and infection when compared with no history of cannabis use.

    Chronic use of large amounts of cannabis has been associated with alteratio…

    Source: , the clinical database we license.

    6 references cited
    1. 115363. Yang G, Li F, Wang Q, Liu Y, Guo J, Yue C. Association between history of cannabis use and outcomes after total hip or knee arthroplasty: a systematic review and meta-analysis. Front Public Health 2024;12:1377688. PubMed
    2. 92673. Reece AS. Severe multisystem dysfunction in a case of high level exposure to smoked cannabis. BMJ Case Rep. 2009;2009. pii: bcr08.2008.0798. PubMed
    3. 118168. Gabbert CT, Bhuiyan F, Truitt TJ. Chasing Highs, Experiencing Lows: A Case of Hypokalemia Associated With Cannabis Use. Cureus 2025;17(4):e83194. PubMed
    4. 110238. Simonsen SK, Rittig NF, Poulsen PL, Svart MV. Hypokalemic paresis in a 26-year-old man after recreational cannabis use. Am J Case Rep 2022;23:e936008. PubMed
    5. 103793. Ammerman SD, Ryan SA, Adelman WP, et al. The impact of marijuana policies on youth: clinical, research, and legal update. Pediatrics. 2015;135(3):584-7. DOI
    6. 104492. Lewis B, Fleeger T, Judge B, Riley B, Jones JS. Acute toxicity associated with cannabis edibles following decriminalization of marijuana in Michigan. Am J Emerg Med. 2020:S0735-6757(20)30872-X. PubMed

Showing the 10 most notable of 65 recorded effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

Everything above comes from the Natural Medicines adverse-effect record for Cannabis — expand a row for the licensed statement it rests on. We haven’t matched Docusate to its FDA label in our system yet, so we can’t compare its own side-effect list here — the leaflet that comes with your prescription is the authoritative list for Docusate.

If You Decide to Take Both
  • Add one new thing at a time, and note the date you started it.
  • A start date turns “I’ve been feeling off” into something a pharmacist can work with.
  • Do not stop a prescribed medicine on your own.
  • Check with your pharmacist or doctor before changing any medicine or supplement, especially if you take several or have an ongoing health condition.

Beyond the Record

What Else We Found About Cannabis and Docusate

Pharmacist Q&AYou ask. We answer.

Questions Our Pharmacists Have Answered About Cannabis and Docusate

Real questions from readers, each answered by a licensed pharmacist at HelloPharmacist, written by a person and not generated from a database. An answer is written for the reader who asked and their situation, so read it for what to ask your own pharmacist rather than as a plan to follow.

Each one covers Cannabis or Docusate, not necessarily both.

  1. The pharmacist says

    Cannabis is not known to have a major documented interaction with binimetinib, though the combination hasn't been formally studied and your oncology team should approve use. Both cannabis and binimetinib can cause drowsiness, dizziness, and other overlapping side effects that may be stronger when used together, so you should monitor how you feel and avoid driving if impaired. Tell your cancer care team exactly what cannabis product you're using and how often so they can watch for any problems during your treatment.

    Answered by Dr. Brian Staiger, PharmD · July 2026
Published Research

Has Anyone Studied Cannabis With Docusate?

No published study names both Cannabis and Docusate. We searched . Most supplement and drug pairs have never been studied together.

Reports to the FDA

134 reports to the FDA list both Cannabis and Docusate.

What this means: someone took both, then had a health problem. It does not show either one caused it. In all 5 newest reports, another medicine was the suspect. These two were 2 of the 13 to 34 products each person was taking.

  • 134Reports that list both
  • 108Marked serious by the reporter
  • 77From doctors, pharmacists and other health professionals
  • 49From patients and other consumers
The 5 Newest Reports
Who sent them, what happened and which medicine was suspected
ReceivedReported byWhat happenedMedicine suspectedCannabisDocusate
August 2026Report 27156711 A consumer Ascites, Vitamin b1 increased, Muscle pain (muscle spasms) Avmapki Fakzynja Co-pack15 products listed Also taking Also taking
May 2026Report 26802372 A physician Meningitis, Candida infection, AphasiaSerious: medically important Vimpat, Briviact34 products listed Also taking Also taking
April 2026Report 26575810 A pharmacist Vomiting, Diarrhea, Vomiting (retching)Serious: hospital stay Daybue Stix, Daybue14 products listed Also taking Also taking
March 2026Report 26528496 A consumer Limb injury, Head injury, FallSerious: medically important Revlimid34 products listed Also taking Also taking
February 2026Report 26411786 A consumer Pustule, Hair loss (alopecia), Diarrhea Avmapki Fakzynja Co-pack13 products listed Also taking Also taking
Problems Named Most Often

Across all 134 reports, whatever was suspected. Not what this pair causes.

  • Tiredness (fatigue)31
  • Diarrhea23
  • Drug ineffective21
  • Shortness of breath (dyspnea)21
  • Pain18
  • Raised blood pressure (hypertension)17
How we searched

PubMed: searched November 2026, and again every few months. PubMed lists research but does not grade it; the finding above comes from our interaction records.

FDA reports: from the FDA Adverse Event Reporting System (FAERS) through openFDA, read November 2026. Matched by name, so a report may name a product that contains Cannabis. The counts are reports, not people, and no one checks them for cause. What FAERS is.

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Cannabis Does Interact With Other Medications

Cannabis has 2 major, 1,110 moderate, 25 minor known drug interactions in our database — Docusate isn’t one of them. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Cannabis

Covers the 2,830 medications we’ve checked against Cannabis. Pick one to open its full report.

Alternatives for the Same Use

Other Supplements for the Same Uses as Cannabis, and How They Mix With Docusate

Choosing a supplement while you take Docusate? Pick what you use Cannabis for to see other options studied for it, and whether each has a documented interaction with Docusate.

What do you take Cannabis for?

For Neuropathic Pain

None of them has a documented interaction with Docusate.

3 other supplements have at least some evidence of a benefit for neuropathic pain. Cannabis itself is graded for it.

For Multiple Sclerosis (MS)

None of them has a documented interaction with Docusate.

2 other supplements have at least some evidence of a benefit for multiple sclerosis (MS). Cannabis itself is graded for it.

The grades come from the Natural Medicines database and describe the research so far, not a recommendation, and none of these supplements replaces a prescribed medicine.

Everything Else You Take

See Every Supplement That Interacts With Docusate

Take other supplements too? 17 supplements have a documented interaction with Docusate, each explained on its page.

By severity: 1 major, 7 moderate and 9 minor.

The Most Serious There Right Now:

Open the Docusate interaction pageEvery supplement checked against Docusate, ranked by severity
One More Smart Check

Taking Cannabis as Part of a Dietary Supplement Product? Check It for Interactions

A product can hold more than Cannabis. We have broken down 21 supplement products that contain it, ingredient by ingredient. Find yours and we’ll check every ingredient against Docusate:

Supplement

About Cannabis

Cannabis

Cannabis contains many active compounds, mainly THC (which causes a 'high') and CBD (which does not). Some uses, such as chemotherapy-related nausea, certain seizure disorders, and muscle spasticity, have meaningful evidence, while many other popular uses are not well proven. It can cause real side effects and impairment, so talk to your doctor or pharmacist and follow your local laws before using it.

Full Cannabis guide: uses, dosage, safety and every interaction

On Its Own

Cannabis Safety

Safety at a Glance

How Cannabis Is Rated

  • Cannabis Overall

    Use caution

    Can cause impairment, dependence, and mental health effects; use carefully and under medical guidance where legal.

  • Pregnancy

    Avoid

    Cannabis is not considered safe in pregnancy and may harm fetal development.

  • Breastfeeding

    Likely Unsafe

    When used orally or inhaled. Delta-9-tetrahydrocannabinol (THC) is concentrated and excreted in breast milk for longer than 6 weeks after cessation of cannabis use.

    Read the full breastfeeding detail ↓

Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center), with the full detail in the next card.

Special Populations

Cannabis in Pregnancy & Breastfeeding

Lactation Likely Unsafe

When used orally or inhaled. Delta-9-tetrahydrocannabinol (THC) is concentrated and excreted in breast milk for longer than 6 weeks after cessation of cannabis use. Prolonged cannabis use during lactation has been associated with delayed motor development. Observational research in mothers who successfully abstained from cannabis use for 6 weeks (confirmed by a negative THC urine screen) after smoking cannabis prenatally at least twice weekly, found that THC levels in breastmilk increased during the first 2 weeks of abstinence and then decreased but remained detectable at 6 weeks. For patients planning to breastfeed, recommend abstaining from cannabis use prenatally and during lactation. Recommendations to discard breastmilk until THC levels are undetectable are not practical, as this may take more than 6 weeks. According to the American College of Obstetrics and Gynecology, cannabis use during lactation is discouraged due to limited long-term safety data in infants.

DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.© 2026 Therapeutic Research Center

More to Explore

More Pairs and Interactions to Check

Keep Checking

Other Drugs & Cannabis

Browse every other medication we’ve checked against Cannabis — both the ones with a known interaction and the ones without. Select any drug for the full detail.

2Major
1,110Moderate
25Minor
1,692No known interaction
Major

Major: 2 interactions

Moderate

Moderate: 1,110 interactions

Showing 60 of 1,110 moderate interactions — see all 1,110 on the Cannabis page.

Minor

Minor: 25 interactions

No Interaction 1,692 drugs checked — show the list

We also checked Cannabis against these medications and found no known interaction in our sources. Open any page to confirm.

Showing 60 of the 1,692 medications checked with no known interaction, the most looked-up first — see the full Cannabis list.

How Much People Look This Up

Where Cannabis and Docusate Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Cannabis
Top 5%

#46 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Docusate
Top 5%

#121 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Cannabis and Docusate Together: Common Questions

Can you take Cannabis with Docusate?
We do not list a known interaction between Cannabis and Docusate. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Can you take Cannabis with Colace?
Colace is a brand name of docusate, so the answer is the same as for docusate. We do not list a known interaction between Cannabis and Docusate. Everything on this page applies to Colace too.
How was the Cannabis and Docusate combination checked?
Interactions in our licensed database are recorded against drug classes. Docusate is filed under 1 classification, and Cannabis has documented interactions with 18 drug classes — none of Docusate's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Do other supplements studied for neuropathic pain interact with Docusate?
None of the 3 other supplements the Natural Medicines database grades as having some evidence of a benefit for neuropathic pain has a documented interaction with Docusate. A grade is the research so far, not a recommendation, and no known interaction is not proof of safety; ask your pharmacist before adding one.
Does Cannabis interact with any other medications?
Yes. Cannabis has 1,137 documented drug interactions in our database — Docusate is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Docusate interact with any supplements?
Yes. Docusate has documented interactions with 17 supplements in our database — Cannabis is not one of them. The Docusate interaction page linked on this page lists every one, ranked by severity.
Has Cannabis been studied with Docusate?
We searched PubMed, the National Library of Medicine's index of medical research, in November 2026, and found no study that names both Cannabis and Docusate. Most supplement and drug pairs have never been studied together, so no known interaction is not the same as proven safe.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Evidence & Sources

References Cited on This Page

The 33 references the cards above cite, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

Show the 33 references
  1. 13. Robbers JE, Speedie MK, Tyler VE. Pharmacognosy and Pharmacobiotechnology. Baltimore, MD: Williams & Wilkins, 1996.
  2. 18. Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc., 1998.
  3. 2619. Hebel SK, ed. Drug Facts and Comparisons. 52nd ed. St. Louis: Facts and Comparisons, 1998.
  4. 17371. Ware MA, Wang T, Shapiro S, et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ 2010;182:e694-e701. PubMed
  5. 61896. Lynch, M. E. and Campbell, F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br.J.Clin.Pharmacol. 2011;72(5):735-744. PubMed
  6. 91920. Jouanjus E, Lapeyre-Mestre M, Micallef J; French Association of the Regional Abuse and Dependence Monitoring Centres (CEIP-A) Working Group on Cannabis Complications. Cannabis use: signal of increasing risk of serious cardiovascular disorders. J Am Heart PubMed
  7. 92673. Reece AS. Severe multisystem dysfunction in a case of high level exposure to smoked cannabis. BMJ Case Rep. 2009;2009. pii: bcr08.2008.0798. PubMed
  8. 96378. Goyal H, Awad HH, Ghali JK. Role of cannabis in cardiovascular disorders. J Thorac Dis. 2017;9(7):2079-2092. PubMed
  9. 96384. Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: A systematic review and meta-analysis. JAMA. 2015;313(24):2456-73. PubMed
  10. 96389. Ocampo TL, Rans TS. Cannabis sativa: the unconventional "weed" allergen. Ann Allergy Asthma Immunol. 2015;114(3):187-92. PubMed
  11. 96813. Lotan I, Treves TA, Roditi Y, Djaldetti R. Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study. Clin Neuropharmacol. 2014;37(2):41-4. PubMed
  12. 96814. Duran M, Pérez E, Abanades S, et al. Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. Br J Clin Pharmacol. 2010;70(5):656-63. PubMed
  13. 99583. Lawn W, Freeman TP, Pope RA, et al. Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses. Psychopharmacology (Berl). 2016;233(19-20):3537-52. PubMed
  14. 99585. Nourbakhsh M, Miller A, Gofton J, Jones G, Adeagbo B. Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases. J Forensic Sci. 2019;64(1):270-274. PubMed
  15. 101420. van de Donk T, Niesters M, Kowal MA, Olofsen E, Dahan A, van Velzen M. An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia. Pain. 2019 Apr;160(4):860-869. PubMed
  16. 101423. Chocron Y, Zuber JP, Vaucher J. Cannabinoid hyperemesis syndrome. BMJ. 2019 Jul 19;366:l4336. PubMed
  17. 101424. Kheifets M, Karniel E, Landa D, Vons SA, Meridor K, Charach G. Resolution of Cannabinoid Hyperemesis Syndrome with Benzodiazepines: A Case Series. Isr Med Assoc J. 2019 Jun;21(6):404-407.
  18. 103793. Ammerman SD, Ryan SA, Adelman WP, et al. The impact of marijuana policies on youth: clinical, research, and legal update. Pediatrics. 2015;135(3):584-7. DOI
  19. 103794. Emoto J, Weeks K, Kallail KJ. Accidental Acute Cannabis Intoxication Presenting as Seizure in Pediatrics Patients. Kans J Med. 2020;13: 129-130. DOI
  20. 104491. Lawin D, Lawrenz T, Tego A, Stellbrink C. Cannabis-induced recurrent myocardial infarction in a 21-year-old man: a case report. Eur Heart J Case Rep. 2020;4(3):1-5. PubMed
  21. 104492. Lewis B, Fleeger T, Judge B, Riley B, Jones JS. Acute toxicity associated with cannabis edibles following decriminalization of marijuana in Michigan. Am J Emerg Med. 2020:S0735-6757(20)30872-X. PubMed
  22. 108688. Kasuda S, Kondo T, Terazawa I, Morimoto M, Yuui K, Kudo R. Cardiac sudden death in a young cannabis user. Leg Med (Tokyo) 2021;53:101955. PubMed
  23. 110238. Simonsen SK, Rittig NF, Poulsen PL, Svart MV. Hypokalemic paresis in a 26-year-old man after recreational cannabis use. Am J Case Rep 2022;23:e936008. PubMed
  24. 110240. Chabot C, Gouat F. Rare finding of acute eosinophilic pneumonia associated with heavy cannabis use: A case-report. Radiol Case Rep 2022;17(9):3040-3042. PubMed
  25. 110242. Englund A, Oliver D, Chesney E, et al. Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios. Neuropsychopharmacology 2022. PubMed
  26. 110254. Hutten NRPW, Arkell TR, Vinckenbosch F, et al. Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis. Psychopharmacology (Berl) 2022;239(11):3731-374 PubMed
  27. 111071. Moussa MK, Hall MAK, Akwe J. Cannabis-induced acute encephalopathy in a 94-year-old woman due to family administration of cannabidiol (CBD) products: A case report. Cureus 2023;15(4):e37927.
  28. 113016. Chhabra M, Ben-Eltriki M, Paul A, Lê ML, Herbert A, Oberoi S, Bradford N, Bowers A, Rassekh SR, Kelly LE. Cannabinoids for symptom management in children with cancer: A systematic review and meta-analysis. Cancer. 2023 Nov 15;129(22):3656-3670. doi: 10.10 PubMed
  29. 115363. Yang G, Li F, Wang Q, Liu Y, Guo J, Yue C. Association between history of cannabis use and outcomes after total hip or knee arthroplasty: a systematic review and meta-analysis. Front Public Health 2024;12:1377688. PubMed
  30. 116443. Storck W, Elbaz M, Vindis C, et al. Cardiovascular risk associated with the use of cannabis and cannabinoids: a systematic review and meta-analysis. Heart. 2025:heartjnl-2024-325429. PubMed
  31. 118162. Ates G, Welsch P, Klose P, et al. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2026;1(1):CD012182. PubMed
  32. 118168. Gabbert CT, Bhuiyan F, Truitt TJ. Chasing Highs, Experiencing Lows: A Case of Hypokalemia Associated With Cannabis Use. Cureus 2025;17(4):e83194. PubMed
  33. 118176. Sebastian SA, Shah Y, Arsene C, Krishnamoorthy G. Cannabis use and atherosclerotic cardiovascular disease outcomes: A meta-analysis of multinational cohort data. Dis Mon 2025;71(3):101849. PubMed

All 258 references behind our Cannabis records are listed in the Cannabis guide.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is reviewed by the HelloPharmacist Editorial Team. See our data sources and editorial standards.

Where Does Our Data Come From?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 105,612 references behind our interaction content, 67,053 of them resolved to verified PubMed/DOI sources. See the references behind this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified November 15, 2026. The Cannabis and Docusate records this page draws on were last updated October 13, 2026.
Data structure & sourcing designed and verified by .
Rating Key

What Our Interaction Ratings Mean

No interaction is on record for this pair. The other supplements and medicines on this page carry a severity rating: how serious an interaction between them is.

See what each severity means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Still Have a Question About Cannabis and Docusate?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.